RankingsPricing
  1. US-listed companies
  2. INSMED Inc
  3. Financials
  4. Research & development

INSMED IncINSM

Market cap
$41.3B
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Dec 31, 2024598+4.79%
Dec 31, 2023571+43.64%
Dec 31, 2022398+45.75%
Dec 31, 2021273+50.56%
Dec 31, 2020181+37.54%
Dec 31, 2019132-9.34%
Dec 31, 2018145+32.38%
Dec 31, 2017110-10.57%
Dec 31, 2016123+65.22%
Dec 31, 201574+31.95%
Dec 31, 201456+27.13%
Dec 31, 201344+48.68%
Dec 31, 201230+6.68%
Dec 31, 201128

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)